Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 18735-74-5 | MDL No. : | MFCD00275475 |
Formula : | C11H9NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YABCPNYCFFUVNM-UHFFFAOYSA-N |
M.W : | 203.19 | Pubchem ID : | 318533 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.09 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 53.86 |
TPSA : | 63.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.93 cm/s |
Log Po/w (iLOGP) : | 1.54 |
Log Po/w (XLOGP3) : | 2.26 |
Log Po/w (WLOGP) : | 2.35 |
Log Po/w (MLOGP) : | 1.19 |
Log Po/w (SILICOS-IT) : | 2.25 |
Consensus Log Po/w : | 1.92 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.85 |
Log S (ESOL) : | -2.93 |
Solubility : | 0.236 mg/ml ; 0.00116 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.23 |
Solubility : | 0.121 mg/ml ; 0.000594 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.52 |
Solubility : | 0.0611 mg/ml ; 0.000301 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.64 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 99924-18-2 ]
5-Phenyloxazole-4-carboxylic acid
Similarity: 0.78
[ 13676-47-6 ]
2-(4-Aminophenyl)benzo[d]oxazol-5-amine
Similarity: 0.78
[ 1455091-10-7 ]
Methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate
Similarity: 0.77
[ 106833-79-8 ]
2-Phenyloxazole-5-carboxylic acid
Similarity: 0.75
[ 1367920-70-4 ]
(2-Phenylbenzo[d]oxazol-6-yl)methanamine
Similarity: 0.74
[ 99924-18-2 ]
5-Phenyloxazole-4-carboxylic acid
Similarity: 0.78
[ 13452-14-7 ]
2-Methyl-1,3-benzoxazole-6-carboxylic acid
Similarity: 0.77
[ 106833-79-8 ]
2-Phenyloxazole-5-carboxylic acid
Similarity: 0.75
[ 90322-32-0 ]
2-Methylbenzo[d]oxazole-5-carboxylic acid
Similarity: 0.72
[ 99924-18-2 ]
5-Phenyloxazole-4-carboxylic acid
Similarity: 0.78
[ 106833-79-8 ]
2-Phenyloxazole-5-carboxylic acid
Similarity: 0.75
[ 103879-58-9 ]
5-Methyloxazole-4-carboxylic acid
Similarity: 0.70
[ 32968-44-8 ]
Ethyl 5-methyloxazole-4-carboxylate
Similarity: 0.69